Table 3.

Concordance between criteria in the diagnosis of gestational diabetes mellitus (GDM)

A – Case-control study: 1999 WHO versus 2015 NICE
1999 WHO∗ 2015 NICE∗ Discordant?n(%)Median HbA1c, mmol/molProportion with HbA1c≥42 mmol/mol
NormalNormalNo233 (44.6)301.7%
NormalGDMYes42 (8.1)3616.7%
GDMNormalYes0--
GDMGDMNo247 (47.3)3722.1%
B – Case-control study: 1999 WHO versus 2013 WHO
1999 WHO∗ 2013 WHO∗ Discordant?n(%)Median HbA1c, mmol/molProportion with HbA1c≥42 mmol/mol
NormalNormalNo213 (40.7)311.4%
NormalGDMYes62 (11.9)3612.9%
GDMNormalYes50 (9.5)348.2%
GDMGDMNo198 (37.9)3826.2%
C – Case-control study: 2015 NICE versus 2013 WHO
2015 NICE∗ 2013 WHO∗ Discordant?n(%)Median HbA1c, mmol/molProportion with HbA1c≥42 mmol/mol
NormalNormalNo213 (40.8)301.4%
NormalGDMYes20 (3.8)335.0%
GDMNormalYes50 (9.6)368.2%
GDMGDMNo239 (45.8)3724.1%
D – Cohort study: 1999 WHO versus 2015 NICE
1999 WHO∗ 2015 NICE∗ Discordant?n(%)Median HbA1c, mmol/molProportion with HbA1c≥42 mmol/mol
NormalNormalNo6138 (88.6)342.5%
NormalGDMYes119 (1.7)3717.7%
GDMNormalYes0--
GDMGDMNo673 (9.7)3822.6%
E – Cohort study: 1999 WHO versus 2013 WHO
1999 WHO∗ 2013 WHO∗ Discordant?n(%)Median HbA1c, mmol/molProportion with HbA1c≥42 mmol/mol
NormalNormalNo5,780 (83.4)332.0%
NormalGDMYes477 (6.9)3713.2%
GDMNormalYes203 (2.9)357.4%
GDMGDMNo470 (6.8)3829.2%
F – Cohort study: 2015 NICE versus 2013 WHO
2015 NICE∗ 2013 WHO∗ Discordant?n(%)Median HbA1c, mmol/molProportion with HbA1c≥42 mmol/mol
NormalNormalNo5,780 (83.4)342.0%
NormalGDMYes358 (5.2)3711.7%
GDMNormalYes203 (2.9)357.4%
GDMGDMNo589 (8.5)3926.8%
  • *Normal is defined as subgroup 1, while GDM is defined as subgroups 2–4 using the categorisation defined in the methods

  • HbA1c = glycated haemoglobin; NICE = National Institute for Health and Care Excellence; WHO = World Health Organization